About this FactMed analysis covering adverse side effect reports of CISPLATIN patients who developed ADHESION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 5 individuals taking CISPLATIN reported ADHESION to the FDA. A total of 28562 CISPLATIN drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between CISPLATIN and ADHESION. In doing so, we compare CISPLATIN with other drugs that cause ADHESION, to help you evaluate whether or not CISPLATIN causes ADHESION. Likewise, this page shows the most highly-reported side effects of CISPLATIN, so you can see if ADHESION ranks among CISPLATIN's most well-known side effects.
Summary Statistics
Reports of CISPLATIN causing ADHESION: 5
Reports of any side effect of CISPLATIN : 28562
Percentage of CISPLATIN patients where ADHESION is a reported side effect: 0.0175%

FDA reports of any drug causing ADHESION : 955
Average percentage for all medicated patients where ADHESION is reported as a complication: 0.0060%

Physician opinion on CISPLATIN as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing CISPLATIN:
NON-SMALL CELL LUNG CANCER ( 3877 patients )
GASTRIC CANCER ( 1526 patients )
HEAD AND NECK CANCER ( 1231 patients )
GASTROOESOPHAGEAL CANCER ( 647 patients )
SQUAMOUS CELL CARCINOMA ( 627 patients )
OESOPHAGEAL CARCINOMA ( 560 patients )
MULTIPLE MYELOMA ( 542 patients )
SMALL CELL LUNG CANCER STAGE UNSPECIFIED ( 477 patients )
NEOPLASM MALIGNANT ( 431 patients )
LUNG NEOPLASM MALIGNANT ( 379 patients )
BLADDER CANCER ( 338 patients )
PLEURAL MESOTHELIOMA MALIGNANT ( 312 patients )
METASTATIC GASTRIC CANCER ( 310 patients )
CHEMOTHERAPY ( 303 patients )
CERVIX CARCINOMA ( 288 patients )
TESTIS CANCER ( 250 patients )
BONE SARCOMA ( 233 patients )
GERM CELL CANCER ( 211 patients )
LUNG ADENOCARCINOMA ( 197 patients )
OESOPHAGEAL ADENOCARCINOMA ( 186 patients )
OVARIAN CANCER ( 186 patients )
NASOPHARYNGEAL CANCER ( 169 patients )
DRUG USE FOR UNKNOWN INDICATION ( 165 patients )
TRANSITIONAL CELL CARCINOMA ( 163 patients )
MESOTHELIOMA ( 160 patients )
NON-SMALL CELL LUNG CANCER STAGE III ( 154 patients )
NON-SMALL CELL LUNG CANCER STAGE IV ( 153 patients )
LARYNGEAL CANCER ( 132 patients )
BREAST CANCER ( 125 patients )
NON-HODGKIN'S LYMPHOMA ( 120 patients )
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED ( 107 patients )
DIFFUSE LARGE B-CELL LYMPHOMA ( 104 patients )
HEPATIC NEOPLASM MALIGNANT ( 104 patients )
OROPHARYNGEAL CANCER STAGE UNSPECIFIED ( 100 patients )
LYMPHOMA ( 99 patients )
MEDULLOBLASTOMA ( 93 patients )
BREAST CANCER METASTATIC ( 91 patients )
PANCREATIC CARCINOMA ( 89 patients )
MANTLE CELL LYMPHOMA ( 87 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 87 patients )
PHARYNGEAL CANCER STAGE UNSPECIFIED ( 85 patients )
TONSIL CANCER ( 84 patients )
SMALL CELL LUNG CANCER EXTENSIVE STAGE ( 84 patients )
OESOPHAGEAL SQUAMOUS CELL CARCINOMA ( 83 patients )
TESTICULAR GERM CELL CANCER ( 82 patients )
LUNG ADENOCARCINOMA STAGE IV ( 73 patients )
ENDOMETRIAL CANCER ( 73 patients )
ANAL CANCER ( 73 patients )
HYPOPHARYNGEAL CANCER ( 72 patients )
ADENOCARCINOMA ( 72 patients )
CARCINOMA ( 71 patients )
LIP AND/OR ORAL CAVITY CANCER ( 65 patients )
LUNG ADENOCARCINOMA METASTATIC ( 65 patients )
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT ( 64 patients )
BRONCHIAL CARCINOMA ( 62 patients )
SQUAMOUS CELL CARCINOMA OF THE CERVIX ( 62 patients )
LUNG CANCER METASTATIC ( 57 patients )
PLEURAL MESOTHELIOMA ( 55 patients )
SARCOMA ( 52 patients )
METASTATIC NEOPLASM ( 51 patients )
B-CELL LYMPHOMA ( 48 patients )
NEUROBLASTOMA ( 48 patients )
NON-SMALL CELL LUNG CANCER METASTATIC ( 46 patients )
NEOPLASM ( 46 patients )
SEMINOMA ( 44 patients )
NON-SMALL CELL LUNG CANCER STAGE IIIB ( 42 patients )
OESOPHAGEAL CANCER METASTATIC ( 41 patients )
BILE DUCT CANCER ( 41 patients )
OVARIAN EPITHELIAL CANCER ( 40 patients )
HODGKIN'S DISEASE ( 38 patients )
CERVIX CARCINOMA RECURRENT ( 37 patients )
MESOTHELIOMA MALIGNANT ( 35 patients )
METASTATIC MALIGNANT MELANOMA ( 35 patients )
GASTRIC CANCER STAGE IV ( 30 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA ( 28 patients )
METASTASES TO LUNG ( 28 patients )
ADENOCARCINOMA PANCREAS ( 26 patients )
MALIGNANT LYMPHOID NEOPLASM ( 26 patients )
LUNG SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED ( 25 patients )
RHABDOMYOSARCOMA ( 25 patients )
FALLOPIAN TUBE CANCER ( 24 patients )
TESTICULAR NEOPLASM ( 24 patients )
BLADDER TRANSITIONAL CELL CARCINOMA ( 24 patients )
THYMOMA ( 24 patients )
HEPATOBLASTOMA ( 24 patients )
SMALL CELL CARCINOMA ( 24 patients )
PLEURAL MESOTHELIOMA MALIGNANT RECURRENT ( 22 patients )
BRAIN NEOPLASM MALIGNANT ( 22 patients )
METASTASES TO LIVER ( 21 patients )
UTERINE CANCER ( 21 patients )
NONGERMINOMATOUS GERM CELL TUMOUR OF THE CNS ( 20 patients )
TESTICULAR SEMINOMA (PURE) ( 20 patients )
MALIGNANT MELANOMA ( 19 patients )
OVARIAN GERM CELL CANCER ( 18 patients )
BRAIN NEOPLASM ( 17 patients )
GLIOBLASTOMA MULTIFORME ( 17 patients )
PRIMITIVE NEUROECTODERMAL TUMOUR ( 17 patients )
ADENOCARCINOMA OF THE CERVIX ( 17 patients )
HEAD AND NECK CANCER METASTATIC ( 16 patients )
GESTATIONAL TROPHOBLASTIC TUMOUR ( 16 patients )
THERAPEUTIC EMBOLISATION ( 16 patients )
CHORIOCARCINOMA ( 16 patients )
EWING'S SARCOMA ( 16 patients )
HEPATIC NEOPLASM MALIGNANT NON-RESECTABLE ( 16 patients )
METASTATIC SQUAMOUS CELL CARCINOMA ( 16 patients )
PENIS CARCINOMA ( 16 patients )
SMALL CELL LUNG CANCER METASTATIC ( 15 patients )
TERATOMA ( 15 patients )
METASTASIS ( 15 patients )
COLON CANCER ( 15 patients )
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED ( 15 patients )
PERITONEAL MESOTHELIOMA MALIGNANT ( 15 patients )
METASTASES TO CENTRAL NERVOUS SYSTEM ( 15 patients )
T-CELL LYMPHOMA ( 15 patients )
TESTICULAR CANCER METASTATIC ( 14 patients )
ILL-DEFINED DISORDER ( 14 patients )
URETHRAL CANCER ( 14 patients )
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA ( 14 patients )
YOLK SAC TUMOUR SITE UNSPECIFIED ( 13 patients )
LUNG ADENOCARCINOMA RECURRENT ( 13 patients )
MALIGNANT PERITONEAL NEOPLASM ( 13 patients )
SMALL CELL LUNG CANCER LIMITED STAGE ( 13 patients )
BLADDER CANCER STAGE IV ( 13 patients )
LUNG ADENOCARCINOMA STAGE III ( 13 patients )
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 ( 13 patients )
HEPATIC NEOPLASM MALIGNANT RESECTABLE ( 13 patients )
LUNG NEOPLASM ( 13 patients )
CERVIX CARCINOMA STAGE IV ( 13 patients )
NASAL SINUS CANCER ( 12 patients )
OVARIAN NEOPLASM ( 12 patients )
ADRENOCORTICAL CARCINOMA ( 12 patients )
ANGIOSARCOMA ( 11 patients )
PROSTATE CANCER ( 11 patients )
NON-SMALL CELL LUNG CANCER STAGE IIIA ( 11 patients )
LUNG SQUAMOUS CELL CARCINOMA STAGE III ( 10 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 10 patients )
PANCREATIC CARCINOMA METASTATIC ( 10 patients )
NON-HODGKIN'S LYMPHOMA STAGE IV ( 10 patients )
MALIGNANT URINARY TRACT NEOPLASM ( 10 patients )
LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED ( 9 patients )
RADIOTHERAPY ( 9 patients )
EPIGLOTTIC CARCINOMA ( 9 patients )
REGIONAL CHEMOTHERAPY ( 9 patients )
METASTASES TO PERITONEUM ( 9 patients )
GALLBLADDER CANCER STAGE IV ( 9 patients )
LARGE CELL LUNG CANCER STAGE IV ( 9 patients )
URETERIC CANCER ( 9 patients )
GASTRIC CANCER RECURRENT ( 9 patients )
METASTATIC CARCINOMA OF THE BLADDER ( 9 patients )
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV ( 9 patients )
OSTEOSARCOMA METASTATIC ( 8 patients )
LEIOMYOSARCOMA ( 8 patients )
PROSTATE CANCER STAGE IV ( 8 patients )
VULVAL CANCER ( 8 patients )
RECTAL CANCER ( 8 patients )
RENAL CANCER ( 8 patients )
STEM CELL TRANSPLANT ( 8 patients )
COLON CANCER METASTATIC ( 8 patients )
ANAL CANCER METASTATIC ( 7 patients )
TESTICULAR EMBRYONAL CARCINOMA ( 7 patients )
THYMOMA MALIGNANT ( 7 patients )
METASTASES TO BONE ( 7 patients )
HEPATIC NEOPLASM MALIGNANT RECURRENT ( 7 patients )
TONGUE NEOPLASM ( 7 patients )
T-CELL LYMPHOMA REFRACTORY ( 7 patients )
TERATOMA OF TESTIS ( 7 patients )
MALIGNANT NEOPLASM OF RENAL PELVIS ( 7 patients )
THYROID CANCER ( 7 patients )
OVARIAN CANCER RECURRENT ( 7 patients )
OESOPHAGEAL NEOPLASM ( 7 patients )
TESTICULAR GERM CELL TUMOUR MIXED STAGE III ( 7 patients )
PANCREATIC NEUROENDOCRINE TUMOUR ( 7 patients )
LIP AND/OR ORAL CAVITY CANCER RECURRENT ( 7 patients )
T-CELL LYMPHOMA STAGE IV ( 6 patients )
AESTHESIONEUROBLASTOMA ( 6 patients )
BRONCHIOLOALVEOLAR CARCINOMA ( 6 patients )
GALLBLADDER CANCER NON-RESECTABLE ( 6 patients )
PITUITARY TUMOUR ( 6 patients )
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT ( 6 patients )
PANCREATIC CARCINOMA STAGE IV ( 6 patients )
FEBRILE NEUTROPENIA ( 6 patients )
SALIVARY GLAND CANCER ( 6 patients )
LARYNGEAL CANCER STAGE IV ( 6 patients )
RENAL CELL CARCINOMA STAGE UNSPECIFIED ( 6 patients )
MALIGNANT HYDATIDIFORM MOLE ( 6 patients )
PSEUDOMYXOMA PERITONEI ( 6 patients )
PINEAL PARENCHYMAL NEOPLASM MALIGNANT ( 5 patients )
MALIGNANT MELANOMA STAGE IV ( 5 patients )
BLADDER NEOPLASM ( 5 patients )
GANGLIONEUROBLASTOMA ( 5 patients )
OVARIAN CANCER METASTATIC ( 5 patients )
CERVIX CANCER METASTATIC ( 5 patients )
METASTASES TO LYMPH NODES ( 5 patients )
NEOPLASM RECURRENCE ( 5 patients )
OVARIAN DYSGERMINOMA STAGE UNSPECIFIED ( 5 patients )
BLADDER CANCER RECURRENT ( 5 patients )
THROAT CANCER ( 5 patients )
LUNG SQUAMOUS CELL CARCINOMA STAGE IV ( 5 patients )
SPINDLE CELL SARCOMA ( 5 patients )
ACUTE MYELOID LEUKAEMIA ( 5 patients )
LARYNGEAL CANCER STAGE 0 ( 5 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY ( 5 patients )
TONGUE CANCER METASTATIC ( 5 patients )
OVARIAN CANCER STAGE III ( 5 patients )
SWEAT GLAND DISORDER ( 5 patients )
DESMOPLASTIC SMALL ROUND CELL TUMOUR ( 4 patients )
MEDULLOBLASTOMA RECURRENT ( 4 patients )
ANAEMIA HAEMOLYTIC AUTOIMMUNE ( 4 patients )
THYMIC CANCER METASTATIC ( 4 patients )
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV ( 4 patients )
Drugs with high FDA adverse event association with ADHESION:

FOSAMAX (219 patients)
VIOXX (200 patients)
HUMIRA (129 patients)
REMICADE (102 patients)
PEGASYS (82 patients)
ACCUTANE (70 patients)
LIPITOR (58 patients)
NEURONTIN (55 patients)
ASPIRIN (46 patients)
AVONEX (45 patients)
SYNTHROID (44 patients)
PRILOSEC (42 patients)
LORAZEPAM (41 patients)
COPEGUS (40 patients)
FOLIC ACID (40 patients)
VITAMIN E (39 patients)
PAXIL (38 patients)
METHOTREXATE (37 patients)
CELEBREX (37 patients)
DIANEAL (37 patients)
PREMARIN (37 patients)
LISINOPRIL (32 patients)
HYDROCHLOROTHIAZIDE (31 patients)
LYRICA (30 patients)
FLOVENT (30 patients)
XANAX (28 patients)
LIORESAL (28 patients)
NORVASC (27 patients)
PREDNISONE (27 patients)
IBUPROFEN (27 patients)
ACTONEL (26 patients)
ALBUTEROL (26 patients)
[THERAPY UNSPECIFIED] (26 patients)
CALCIUM (UNSPECIFIED) (26 patients)
DIGOXIN (25 patients)
AMBIEN (25 patients)
PROTONIX (25 patients)
FUROSEMIDE (24 patients)
ATENOLOL (24 patients)
LASIX (23 patients)
OXYCONTIN (23 patients)
NEXIUM (23 patients)
FLEXERIL (22 patients)
ACETAMINOPHEN (21 patients)
FOSAMAX PLUS D (21 patients)
ZANTAC (21 patients)
ZOLOFT (21 patients)
EVISTA (21 patients)
VITAMIN D (21 patients)
CIPRO (20 patients)
LEVOTHYROXINE SODIUM (20 patients)
FORTEO (19 patients)
PREDNISONE TAB (19 patients)
LANOXIN (19 patients)
LEXAPRO (18 patients)
ACIPHEX (18 patients)
LORTAB (18 patients)
COUMADIN (18 patients)
OMEPRAZOLE (18 patients)
FLUOROURACIL (18 patients)
VERAPAMIL (17 patients)
VITAMINS (UNSPECIFIED) (17 patients)
PERCOCET (17 patients)
HYDROCODONE BITARTRATE (17 patients)
TRAZODONE HYDROCHLORIDE (17 patients)
CLARITIN (17 patients)
CLONAZEPAM (17 patients)
MULTI-VITAMIN (17 patients)
MYCOPHENOLATE MOFETIL (16 patients)
DETROL LA (16 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (16 patients)
SEROQUEL (16 patients)
AMITRIPTYLINE HYDROCHLORIDE (16 patients)
AMPICILLIN (16 patients)
ZOFRAN (16 patients)
VALIUM (15 patients)
CYANOCOBALAMIN (14 patients)
ALPRAZOLAM (14 patients)
WARFARIN SODIUM (14 patients)
VICODIN (14 patients)
ACYCLOVIR (13 patients)
LEVAQUIN (13 patients)
ROBAXIN (13 patients)
ALENDRONATE SODIUM (13 patients)
DECADRON (13 patients)
MORPHINE (13 patients)
VITAMIN B-12 (13 patients)
BACTRIM DS (13 patients)
ZELNORM (13 patients)
CIMZIA (13 patients)
ENTOCORT EC (13 patients)
ALTACE (12 patients)
VENTOLIN (12 patients)
K-DUR 10 (12 patients)
LEUCOVORIN CALCIUM (12 patients)
CYMBALTA (12 patients)
DEXAMETHASONE (12 patients)
MIRENA (12 patients)
GOLIMUMAB (12 patients)
HORMONES (UNSPECIFIED) (12 patients)
PREVACID (12 patients)
PRIMIDONE (12 patients)
CITALOPRAM HYDROBROMIDE (12 patients)
FENTANYL (12 patients)
VYTORIN (12 patients)
VITAMIN D (UNSPECIFIED) (11 patients)
ZOCOR (11 patients)
PREDNISOLONE (11 patients)
DOXORUBICIN HCL (11 patients)
POTASSIUM CHLORIDE (11 patients)
OYST CAL D (11 patients)
FAMOTIDINE (11 patients)
REGLAN (11 patients)
WELLBUTRIN (11 patients)
GABAPENTIN (11 patients)
OXYCODONE HCL (11 patients)
ZETIA (11 patients)
DULCOLAX (11 patients)
URBASON (11 patients)
CLOZARIL (11 patients)
CLONIDINE (11 patients)
RANITIDINE (11 patients)
REBIF (10 patients)
PREMPRO (10 patients)
YAZ (10 patients)
CLONOPIN (10 patients)
ESTRATEST (10 patients)
VITAMINS (10 patients)
ASCORBIC ACID (10 patients)
TOCILIZUMAB (10 patients)
DEPAKOTE (10 patients)
MIACALCIN (10 patients)
DOSTINEX (10 patients)
BACLOFEN (10 patients)
CELEXA (10 patients)
NITROSTAT (10 patients)
LANTUS (10 patients)
CALCIUM (10 patients)
DIFLUCAN (9 patients)
ENBREL (9 patients)
ONDANSETRON (9 patients)
TEGRETOL (9 patients)
PROMETHAZINE (9 patients)
INDAPAMIDE (9 patients)
ADVAIR DISKUS 100/50 (9 patients)
PLAVIX (9 patients)
LANSOPRAZOLE (9 patients)
TACROLIMUS (9 patients)
AMOXICILLIN (9 patients)
IMURAN (9 patients)
MULTI-VITAMINS (9 patients)
DIOVAN (9 patients)
MORPHINE SULFATE (9 patients)
CENTRUM (9 patients)
BIRTH CONTROL PILLS (9 patients)
ESTRADIOL (9 patients)
CALCIUM GLUCONATE (9 patients)
LUPRON DEPOT (9 patients)
FISH OIL (9 patients)
DICLOFENAC (9 patients)
CALCIUM CARBONATE (9 patients)
LOVENOX (8 patients)
MIRALAX (8 patients)
SALAGEN (8 patients)
CELECOXIB (8 patients)
ULTRAM (8 patients)
DEPO-PROVERA (8 patients)
TRAZODONE HCL (8 patients)
SK-ERYTHROMYCIN (8 patients)
MIRAPEX (8 patients)
VALTREX (8 patients)
TYLENOL (CAPLET) (8 patients)
YASMIN (8 patients)
RENAGEL (8 patients)
SERTRALINE HYDROCHLORIDE (8 patients)
CRESTOR (8 patients)
CARTICEL (8 patients)
AUGMENTIN '125' (8 patients)
DICLOFENAC SODIUM (8 patients)
AVASTIN (8 patients)
PENTASA (8 patients)
VELCADE (8 patients)
VANCOMYCIN (8 patients)
VINCRISTINE (8 patients)
PROGRAF (8 patients)
FLAGYL (8 patients)
UNCODEABLE ^UNCLASSIFIABLE^ (7 patients)
ELIDEL (7 patients)
FLOXIN OTIC (7 patients)
ACTOS (7 patients)
CLINDAMYCIN (7 patients)
IMIPRAMINE (7 patients)
OXALIPLATIN (7 patients)
AMITRIPTYLINE HCL (7 patients)
CIPROFLOXACIN (7 patients)
NIFEDIPINE (7 patients)
LAMICTAL (7 patients)
COZAAR (7 patients)
WARFARIN (7 patients)
FLORINEF (7 patients)
METOPROLOL (7 patients)
HUMALOG (7 patients)
BEVACIZUMAB (7 patients)
ISONIAZID (7 patients)
KLONOPIN (7 patients)
PROZAC (7 patients)
CALCICHEW (7 patients)
PYRIDIUM (7 patients)
RAMIPRIL (7 patients)
NUVARING (7 patients)
Most common side effects for patients taking CISPLATIN:
NAUSEA (2633 patients)
DEHYDRATION (2627 patients)
VOMITING (2579 patients)
DIARRHOEA (2080 patients)
NEUTROPENIA (1972 patients)
FEBRILE NEUTROPENIA (1849 patients)
PYREXIA (1721 patients)
ANAEMIA (1597 patients)
THROMBOCYTOPENIA (1433 patients)
PNEUMONIA (1335 patients)
FATIGUE (1181 patients)
DYSPNOEA (1139 patients)
MUCOSAL INFLAMMATION (1135 patients)
RENAL FAILURE ACUTE (1129 patients)
PULMONARY EMBOLISM (1062 patients)
ASTHENIA (1040 patients)
HAEMOGLOBIN DECREASED (1021 patients)
SEPSIS (956 patients)
WHITE BLOOD CELL COUNT DECREASED (946 patients)
RENAL FAILURE (943 patients)
PLATELET COUNT DECREASED (895 patients)
HYPOTENSION (878 patients)
LEUKOPENIA (834 patients)
DYSPHAGIA (823 patients)
HYPOKALAEMIA (812 patients)
HYPONATRAEMIA (809 patients)
ABDOMINAL PAIN (772 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (759 patients)
MALIGNANT NEOPLASM PROGRESSION (740 patients)
DEATH (740 patients)
STOMATITIS (675 patients)
DECREASED APPETITE (663 patients)
BLOOD CREATININE INCREASED (659 patients)
PANCYTOPENIA (641 patients)
DEEP VEIN THROMBOSIS (636 patients)
NEUTROPHIL COUNT DECREASED (619 patients)
WEIGHT DECREASED (613 patients)
PAIN (548 patients)
SEPTIC SHOCK (538 patients)
RESPIRATORY FAILURE (517 patients)
CONSTIPATION (500 patients)
ANOREXIA (500 patients)
DISEASE PROGRESSION (483 patients)
DIZZINESS (472 patients)
PLEURAL EFFUSION (460 patients)
HYPOMAGNESAEMIA (443 patients)
CONFUSIONAL STATE (438 patients)
INFECTION (433 patients)
SYNCOPE (408 patients)
CHEST PAIN (384 patients)
RASH (383 patients)
OESOPHAGITIS (374 patients)
ATRIAL FIBRILLATION (368 patients)
INTERSTITIAL LUNG DISEASE (357 patients)
HYPERTENSION (357 patients)
CONVULSION (355 patients)
HYPOCALCAEMIA (354 patients)
MALAISE (353 patients)
NEUTROPENIC SEPSIS (349 patients)
URINARY TRACT INFECTION (345 patients)
TACHYCARDIA (325 patients)
RENAL IMPAIRMENT (323 patients)
BONE MARROW FAILURE (321 patients)
DRUG TOXICITY (319 patients)
CHILLS (318 patients)
BLOOD SODIUM DECREASED (309 patients)
HEADACHE (305 patients)
OEDEMA PERIPHERAL (298 patients)
GASTROINTESTINAL HAEMORRHAGE (296 patients)
COUGH (285 patients)
FALL (285 patients)
HAEMATOCRIT DECREASED (280 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (272 patients)
MULTI-ORGAN FAILURE (272 patients)
HYPOXIA (268 patients)
MYOCARDIAL INFARCTION (268 patients)
ALANINE AMINOTRANSFERASE INCREASED (268 patients)
BACK PAIN (253 patients)
LOSS OF CONSCIOUSNESS (251 patients)
HAEMOPTYSIS (250 patients)
PNEUMONIA ASPIRATION (242 patients)
BLOOD POTASSIUM DECREASED (241 patients)
CARDIAC ARREST (239 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (233 patients)
NEOPLASM MALIGNANT (232 patients)
BLOOD UREA INCREASED (232 patients)
HYPERGLYCAEMIA (230 patients)
BLOOD PRESSURE DECREASED (225 patients)
ELECTROLYTE IMBALANCE (224 patients)
ASCITES (223 patients)
CARDIAC FAILURE (213 patients)
STAPHYLOCOCCAL INFECTION (211 patients)
EPISTAXIS (211 patients)
THROMBOSIS (211 patients)
PNEUMONITIS (202 patients)
ERYTHEMA (199 patients)
CEREBRAL INFARCTION (198 patients)
CARDIO-RESPIRATORY ARREST (197 patients)
ABDOMINAL PAIN UPPER (191 patients)
CEREBROVASCULAR ACCIDENT (191 patients)
FEBRILE BONE MARROW APLASIA (189 patients)
NEOPLASM PROGRESSION (187 patients)
DRUG INTERACTION (186 patients)
ANXIETY (186 patients)
LYMPHOPENIA (185 patients)
HYPERKALAEMIA (184 patients)
PULMONARY OEDEMA (184 patients)
ORAL INTAKE REDUCED (183 patients)
RESPIRATORY DISTRESS (183 patients)
CONDITION AGGRAVATED (181 patients)
OFF LABEL USE (180 patients)
DRUG INEFFECTIVE (180 patients)
COLITIS (179 patients)
NEUROPATHY PERIPHERAL (178 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (177 patients)
ARTHRALGIA (177 patients)
HAEMORRHAGE (175 patients)
SUDDEN DEATH (174 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (173 patients)
BLOOD BILIRUBIN INCREASED (168 patients)
SOMNOLENCE (167 patients)
OSTEONECROSIS (164 patients)
HYPOALBUMINAEMIA (163 patients)
HYPOPHAGIA (163 patients)
WHITE BLOOD CELL COUNT INCREASED (163 patients)
PAIN IN EXTREMITY (162 patients)
PARAESTHESIA (162 patients)
C-REACTIVE PROTEIN INCREASED (161 patients)
BLOOD GLUCOSE INCREASED (161 patients)
TUMOUR LYSIS SYNDROME (161 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (156 patients)
ILEUS (151 patients)
BLOOD ALBUMIN DECREASED (150 patients)
MENTAL STATUS CHANGES (149 patients)
SHOCK (149 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (148 patients)
ACUTE MYELOID LEUKAEMIA (147 patients)
ACUTE MYOCARDIAL INFARCTION (147 patients)
MALNUTRITION (146 patients)
DEPRESSION (146 patients)
COMA (145 patients)
PERIPHERAL ISCHAEMIA (143 patients)
ORAL PAIN (138 patients)
BLOOD MAGNESIUM DECREASED (137 patients)
MYELODYSPLASTIC SYNDROME (135 patients)
HEART RATE INCREASED (134 patients)
BLOOD CALCIUM DECREASED (134 patients)
PERITONITIS (133 patients)
METABOLIC ACIDOSIS (132 patients)
PRODUCTIVE COUGH (131 patients)
HEPATIC FUNCTION ABNORMAL (131 patients)
LUNG INFILTRATION (130 patients)
DISORIENTATION (129 patients)
CELLULITIS (129 patients)
HAEMATEMESIS (129 patients)
RED BLOOD CELL COUNT DECREASED (129 patients)
INSOMNIA (126 patients)
LARGE INTESTINE PERFORATION (125 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (125 patients)
LYMPHOCYTE COUNT DECREASED (124 patients)
HYPERSENSITIVITY (124 patients)
CEREBRAL ISCHAEMIA (123 patients)
ATELECTASIS (122 patients)
PNEUMOTHORAX (122 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (122 patients)
METASTASES TO CENTRAL NERVOUS SYSTEM (120 patients)
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (120 patients)
LUNG INFECTION (120 patients)
ODYNOPHAGIA (120 patients)
PRURITUS (120 patients)
BLOOD CULTURE POSITIVE (119 patients)
SMALL INTESTINAL OBSTRUCTION (118 patients)
HYPERHIDROSIS (118 patients)
PERICARDIAL EFFUSION (117 patients)
OEDEMA (117 patients)
LUNG DISORDER (117 patients)
ENCEPHALOPATHY (116 patients)
HYPOPHOSPHATAEMIA (115 patients)
OXYGEN SATURATION DECREASED (114 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (113 patients)
HYPOVOLAEMIA (112 patients)
PERFORMANCE STATUS DECREASED (112 patients)
HAEMATURIA (112 patients)
HAEMATOTOXICITY (111 patients)
MUSCULAR WEAKNESS (110 patients)
ALOPECIA (110 patients)
HEPATIC FAILURE (110 patients)
BRADYCARDIA (110 patients)
RECTAL HAEMORRHAGE (109 patients)
NEPHROPATHY TOXIC (109 patients)
CIRCULATORY COLLAPSE (109 patients)
BODY TEMPERATURE INCREASED (109 patients)
ORTHOSTATIC HYPOTENSION (108 patients)
GASTRITIS (108 patients)
HYPOAESTHESIA (107 patients)
LETHARGY (107 patients)
LIVER DISORDER (104 patients)
TREMOR (104 patients)
HYDRONEPHROSIS (103 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (103 patients)
SINUS TACHYCARDIA (102 patients)
ABDOMINAL DISTENSION (101 patients)
PHARYNGOLARYNGEAL PAIN (101 patients)
BACTERAEMIA (100 patients)
BRONCHOPNEUMONIA (100 patients)
METASTASES TO LIVER (100 patients)
PULMONARY FIBROSIS (99 patients)
BRONCHITIS (99 patients)
ILEUS PARALYTIC (99 patients)
CANDIDIASIS (99 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for CISPLATIN


Issue Description / Topic Timestamp
QUESTION
VASCULITIS NECROTISING
what is the cause of cisplatin induced gangrene 2015-02-23 04:53:53
QUESTION
INFREQUENT BOWEL MOVEMENTS
Husband on cisplatin for lung cancer. Not constipated but poops less. Is this normal? 2016-04-10 20:59:10
QUESTION
IMPAIRED DRIVING ABILITY
Cisplatan impair driving? 2016-06-23 17:02:24
QUESTION
MYOCARDIAL ISCHAEMIA
Regarding I-25 — the cyclist was seen around the I-225 Inhntcraege in south Denver near the Denver Tech Center. No cycling is permitted on the Interstates through Denver, and the Tech Center area is well connected with bike facilities (I used to bike from downtown Denver to meetings at the DTC). 2017-03-20 08:49:23

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ADHESION and CISPLATIN, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking CISPLATIN, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in CISPLATIN. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for CISPLATIN experts. If you are a healthcare provider experienced in prescribing CISPLATIN, please register here.

Your online appointment book for Horseshoe Bend Rentals & Services

Chef and Catering services in Horseshoe Bend
Chiropracter and Massage services in Horseshoe Bend
Event and Wedding Planning services in Horseshoe Bend
Hair Styling services in Horseshoe Bend
Personal Shopping services in Horseshoe Bend
Photography and Videography services in Horseshoe Bend
Private Investigation services in Horseshoe Bend
Website Design services in Horseshoe Bend

Home
Appliance Repair services in Horseshoe Bend
Appraisals services in Horseshoe Bend
Awnings services in Horseshoe Bend
Builder Services services in Horseshoe Bend
Carpentry services in Horseshoe Bend
Cleaning services in Horseshoe Bend
Decks and Porches services in Horseshoe Bend
Electricians services in Horseshoe Bend
Fireplace services in Horseshoe Bend
Generators services in Horseshoe Bend
Greenhouses and Nurseries services in Horseshoe Bend
Handymen services in Horseshoe Bend
Home Security services in Horseshoe Bend
HVAC services in Horseshoe Bend
Insulation services in Horseshoe Bend
Interior Design services in Horseshoe Bend
Landscaping services in Horseshoe Bend
Lawn and Yard services in Horseshoe Bend
Locksmiths services in Horseshoe Bend
Marble and Granite Experts services in Horseshoe Bend
Masonry services in Horseshoe Bend
Moving Services services in Horseshoe Bend
Painters services in Horseshoe Bend
Plumbing services in Horseshoe Bend
Pool and Spa services in Horseshoe Bend
Property Management services in Horseshoe Bend
Roofers services in Horseshoe Bend
Snow Plowing services in Horseshoe Bend
Solar Power Consultants services in Horseshoe Bend
Upholstery services in Horseshoe Bend
Wallpaper services in Horseshoe Bend
Waterproofing services in Horseshoe Bend
Windows services in Horseshoe Bend
Services - Other



© 2014 FactMed, Inc
Privacy Policy
Terms of Use